Skip to main content

venBio Partners LLC

SEC CIK
0001776382
Latest filing
Aug 14, 2026

Holdings in Q4 2021

Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.

Institution overview
Positions
9
0 vs. Q3 2021
Portfolio value
$555.1M
−$448.7M (−44.7%) vs. Q3 2021
Filed
Feb 14, 2022
SEC
Holdings of venBio Partners LLC in Q4 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
ALXOAlx Oncology Holdings IncCOM9,699,925$208.5M37.6%00.0%UnchangedHistory
HRMYHarmony Biosciences Holdings, Inc.COM2,740,411$116.9M21.1%−322,783−10.5%ReducedHistory
VTYXVentyx Biosciences, Inc.COM5,011,536$99.5M17.9%+5,011,536NewHistory
AKROAkero Therapeutics, Inc.COM2,171,664$45.9M8.3%−29,114−1.3%ReducedHistory
PHVSPharvaris N.V.COM2,303,310$33.1M6.0%00.0%UnchangedHistory
IMPLIPI Legacy Liquidation CoCOM2,759,791$23.8M4.3%00.0%UnchangedHistory
ELEVElevation Acquisition Group Inc.COM2,608,167$15.7M2.8%00.0%UnchangedHistory
CMPICheckmate Pharmaceuticals, Inc.COM3,673,374$10.5M1.9%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS161,897$1.09M0.2%00.0%UnchangedHistory

Sold out since Q3 2021 (1)

Positions held at the end of Q3 2021 that are gone from this filing.

Positions of venBio Partners LLC sold out since Q3 2021
SecurityClassShares in Q3 2021Value in Q3 2021% of portfolio in Q3 2021History
MTCRMetacrine, Inc.COM3,059,123$10.5M1.0%History